Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cardiff Oncology, Inc. (CRDF) had Receiveable Turnover of 1.69 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.49M |
|
$-41.47M |
|
-- |
|
$0.49M |
|
$45.90M |
|
$-45.41M |
|
$3.97M |
|
$-41.44M |
|
$-41.44M |
|
$-41.44M |
|
$-41.44M |
|
$-41.44M |
|
$-41.44M |
|
$-45.41M |
|
$-45.94M |
|
44.68M |
|
44.68M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$77.41M |
|
$1.24M |
|
$4.22M |
|
$81.64M |
|
$10.44M |
|
-- |
|
$1.46M |
|
$11.90M |
|
$69.74M |
|
$69.74M |
|
$69.74M |
|
44.68M |
|
| Cash Flow Statement Financials | |
$-30.89M |
|
$36.20M |
|
-- |
|
$16.35M |
|
$21.66M |
|
$5.31M |
|
$4.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-9305.74% |
|
-9305.74% |
|
-9412.91% |
|
-8492.01% |
|
-8496.93% |
|
$-31.47M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
|
Receiveable Turnover |
1.69 |
215.41 |
|
-59.42% |
|
-59.42% |
|
-50.76% |
|
-59.42% |
|
$1.56 |
|
$-0.70 |
|
$-0.69 |
|